// App-Quantinova.ai

BSH19‐PO‐193 : Erythropoietic Stimulating Agents for Pure Red Cell Aplasia Following Major ABO Mismatch T‐deplete Allogeneic Stem Cell Transplants

Researchers

Presenter

  • V. Mehra

Principal Investigators

  • O. Pearse

  • R. Walker

  • H. de lavallade

  • D. Mclornan

  • T. Pagliuca

  • G. Mufti

  • K. Raj

  • V. Potter

Medical Centers

  • Haematological Medicine, Kings College Hospital

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Acute myelocytic leukemia

  • Acquired pure red cell aplasia

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

  • Recombinant human erythropoietin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved